Literature DB >> 24299613

Incidence of type II diabetes in a cohort with substantial exposure to perfluorooctanoic acid.

Conny Karnes1, Andrea Winquist2, Kyle Steenland2.   

Abstract

BACKGROUND: Research suggests an increased type II diabetes mortality risk among workers occupationally exposed to PFOA. However, a cross-sectional study of highly exposed Mid-Ohio Valley community residents did not demonstrate an association between PFOA and type II diabetes.
OBJECTIVES: We examined the relationship between exposure to PFOA over time and incidence of type II diabetes in a cohort of community residents and workers exposed to high levels of PFOA via contaminated drinking water.
METHODS: Community residents and workers were interviewed in 2008-2011 to obtain medical history and other demographic information. Cumulative serum PFOA exposure estimates were calculated based on residence and occupation locations, and a history of plant emissions. We estimated the risk of developing type II diabetes using Cox proportional hazard models, controlling for demographic characteristics and family history.
RESULTS: Out of 32,254 survey respondents, there were 4434 cases of self-reported type II diabetes, of which 4129 were validated through medical record review. In analyses based on validated type II diabetes, there was no trend of increased risk with increased cumulative PFOA serum levels (HRs compared to lowest exposure decile: 0.91 (95% CI: 0.76-1.08), 1.18 (95% CI: 0.99-1.40), 0.96 (95% CI: 0.81-1.15), 1.04 (95% CI: 0.87-1.24), 1.11 (95% CI: 0.93-1.32), 1.06 (95% CI: 0.89-1.26), 1.00 (95% CI: 0.85-1.19), 1.03 (95% CI: 0.86-1.23), 1.01 (95% CI: 0.84-1.20)). There was no association between fasting glucose level and cumulative serum levels of PFOA, after excluding diabetics.
CONCLUSIONS: We do not find an association between PFOA exposure and incidence of type II diabetes.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  C8; C8 Science Panel; Diabetes; Perfluorooctanoic acid

Mesh:

Substances:

Year:  2013        PMID: 24299613     DOI: 10.1016/j.envres.2013.11.003

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  20 in total

1.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

2.  Perfluoroalkyl substances are inversely associated with coronary heart disease in adults with diabetes.

Authors:  Kyoko Honda-Kohmo; Robert Hutcheson; Kim E Innes; Baqiyyah N Conway
Journal:  J Diabetes Complications       Date:  2019-02-20       Impact factor: 2.852

3.  Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.

Authors:  Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate
Journal:  Int J Hyg Environ Health       Date:  2019-08-20       Impact factor: 5.840

4.  Associations of Perfluoroalkyl and Polyfluoroalkyl Substances With Incident Diabetes and Microvascular Disease.

Authors:  Andres Cardenas; Marie-France Hivert; Diane R Gold; Russ Hauser; Ken P Kleinman; Pi-I D Lin; Abby F Fleisch; Antonia M Calafat; Xiaoyun Ye; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Diabetes Care       Date:  2019-07-11       Impact factor: 19.112

Review 5.  Endocrine-disrupting chemicals: implications for human health.

Authors:  Linda G Kahn; Claire Philippat; Shoji F Nakayama; Rémy Slama; Leonardo Trasande
Journal:  Lancet Diabetes Endocrinol       Date:  2020-08       Impact factor: 32.069

Review 6.  Association between per- and polyfluoroalkyl substances exposure and risk of diabetes: a systematic review and meta-analysis.

Authors:  Si-Yu Gui; Jian-Chao Qiao; Ke-Xin Xu; Ze-Lian Li; Yue-Nan Chen; Ke-Jia Wu; Zheng-Xuan Jiang; Cheng-Yang Hu
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-08-15       Impact factor: 6.371

7.  Per- and polyfluoroalkyl substances and incident diabetes in midlife women: the Study of Women's Health Across the Nation (SWAN).

Authors:  Sung Kyun Park; Xin Wang; Ning Ding; Carrie A Karvonen-Gutierrez; Antonia M Calafat; William H Herman; Bhramar Mukherjee; Siobán D Harlow
Journal:  Diabetologia       Date:  2022-04-11       Impact factor: 10.460

8.  The role of pollutants in type 2 diabetes mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Lukhanyo Mekuto; Tandi Matsha; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2018-04-02       Impact factor: 2.513

9.  Perfluoroalkyl substances and beta cell deficient diabetes.

Authors:  Baqiyyah Conway; Karen E Innes; Dustin Long
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

Review 10.  Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.

Authors:  Suzanne E Fenton; Alan Ducatman; Alan Boobis; Jamie C DeWitt; Christopher Lau; Carla Ng; James S Smith; Stephen M Roberts
Journal:  Environ Toxicol Chem       Date:  2020-12-07       Impact factor: 4.218

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.